Review:
21 Cfr Part 820 (fda Quality System Regulation)
overall review score: 4.2
⭐⭐⭐⭐⭐
score is between 0 and 5
21 CFR Part 820 is a section of the Code of Federal Regulations established by the U.S. Food and Drug Administration (FDA) that outlines current good manufacturing practices (CGMP) for medical devices. It sets forth requirements for quality systems, including design controls, document controls, purchasing controls, production and process controls, corrective and preventive actions, and recordkeeping to ensure that medical devices are safe and effective for use.
Key Features
- Establishes comprehensive quality system requirements for medical device manufacturing
- Requires documented procedures for design, production, and servicing processes
- Emphasizes risk management and design controls
- Mandates thorough recordkeeping and documentation practices
- Includes provisions for corrective and preventive actions (CAPA)
- Ensures supplier control and verification processes
- Supports compliance with FDA regulations and international standards
Pros
- Promotes high quality standards in medical device manufacturing
- Enhances patient safety through rigorous controls
- Provides clear regulatory guidance for manufacturers
- Supports consistent product quality across production runs
- Encourages continuous improvement within quality systems
Cons
- Can be complex and challenging to fully implement for small businesses
- Requires extensive documentation which may increase administrative burden
- Non-compliance can result in regulatory actions or product recalls
- Implementation costs can be substantial for startups or low-volume manufacturers